US OptionsDetailed Quotes

CRVS240816P2000

Watchlist

0.15
-0.05-25.00%

15min DelayClose Jul 22 16:00 ET

0.15High0.15Low

Corvus Pharmaceuticals Stock Discussion

leo1212

May 29 10:55

any news coming?

$Corvus Pharmaceuticals(CRVS.US)$

Trytosaveabit

May 9 03:46

New 13D/A

$Corvus Pharmaceuticals(CRVS.US)$ Corvus Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.1%),OrbiMed Capital GP V LLC(11.1%)

Trytosaveabit

May 7 16:16

Nice! Insider buy! Can you say holy big buy! Hehehe

$Corvus Pharmaceuticals(CRVS.US)$ Richard A Miller, Director, President and CEO, on May 06, 2024, executed a purchase for 577,634 shares in Corvus Pharmaceuticals (CRVS) for $1,000,000. Following the Form 4 filing with the SEC, Miller has control over a total of 2,067,753 shares of the company, with 577,634 shares held directly and 1,490,119 controlled indirectly.

Trytosaveabit

May 7 07:13

$Corvus Pharmaceuticals(CRVS.US)$ Oppenheimer Maintains Outperform on Corvus Pharma, Raises Price Target to $8

Trytosaveabit

May 6 15:55

Someone else must like? Hehehe

$Corvus Pharmaceuticals(CRVS.US)$ Reuters· 2 mins Corvus Pharmaceuticals - Issue and Sell to Investors in Registered Direct Offering Aggregate of 13.5 Mln Shares of Common Stock, Among Others

Trytosaveabit

May 6 15:54

A bit of why I like!

$Corvus Pharmaceuticals(CRVS.US)$ Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024
Soquelitinib Registration Phase 3 Trial in Peripheral T Cell Lymphoma Advancing Toward Initial Enrollment in Q3 2024
Interim Data from Ciforadenant Phase 1b/2 Trial in Front Line Renal Cell Cancer Exceeds Predefin...

Trytosaveabit

May 6 06:06

Getting a bit of attention?

$Corvus Pharmaceuticals(CRVS.US)$

Jaguar8

May 2 07:34

$Corvus Pharmaceuticals(CRVS.US)$
NEWS
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering

Jaguar8

Apr 9 15:01

$Corvus Pharmaceuticals(CRVS.US)$
NEWS
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Trytosaveabit

Mar 20 06:19

I don’t put much credibility in analysts PT’s because they mis so often! Hehehe

$Corvus Pharmaceuticals(CRVS.US)$ But its nice to see when i do agree! Even lower by a buck 7 would still be killer gains! LMAO. ((((((. Oppenheimer analyst Jeff Jones maintains Corvus Pharma (NASDAQ:CRVS) with a Outperform and lowers the price target from $8 to $7. )))))

No comment yet